American Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.29M Sell
5,752
-575
-9% -$583K 0.47% 30
2025
Q4
$6.8M Sell
6,327
-58
-0.9% -$55.5K 0.57% 27
2025
Q3
$4.87M Buy
6,385
+263
+4% +$196K 0.41% 39
2025
Q2
$4.77M Buy
6,122
+3,644
+147% +$2.83M 0.45% 34
2025
Q1
$2.05M Sell
2,478
-109
-4% -$90.7K 0.5% 57
2024
Q4
$2M Sell
2,587
-16
-0.6% -$13.2K 0.15% 89
2024
Q3
$2.31M Buy
2,603
+115
+5% +$103K 0.19% 72
2024
Q2
$2.25M Sell
2,488
-5
-0.2% -$4K 0.18% 76
2024
Q1
$1.94M Buy
2,493
+14
+0.6% +$9.96K 0.16% 81
2023
Q4
$1.45M Sell
2,479
-61
-2% -$35.6K 0.11% 87
2023
Q3
$1.36M Sell
2,540
-135
-5% -$69.6K 0.11% 90
2023
Q2
$1.25M Buy
2,675
+743
+38% +$312K 0.09% 119
2023
Q1
$663K Sell
1,932
-1
-0.1% -$337 0.05% 175
2022
Q4
$707K Buy
1,933
+20
+1% +$7.09K 0.07% 163
2022
Q3
$619K Hold
1,913
0.05% 161
2022
Q2
$620K Sell
1,913
-331
-15% -$99.4K 0.05% 181
2022
Q1
$643K Hold
2,244
0.04% 205
2021
Q4
$620K Buy
+2,244
New +$569K 0.05% 148

Other funds holding LLY

American Trust's LLY Position: Q1 2026 in Review

American Trust reduced its Eli Lilly (LLY) stake by 9.1% in Q1 2026, selling an estimated $583K and leaving 5,752 shares worth $5.29M. The position accounts for 0.47% of the portfolio, ranked #30.

American Trust first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.8M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • American Trust held 5,752 shares of Eli Lilly worth $5.29M as of Q1 2026.
  • American Trust sold 575 Eli Lilly shares in Q1 2026, an estimated $583K.
  • Eli Lilly made up 0.47% of American Trust's portfolio in Q1 2026, its #30 holding.
  • American Trust first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • American Trust's Eli Lilly position peaked at $6.8M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.